1) amyotrophic lateral sclerosis
肌萎缩侧索硬化
1.
Progress of drug therapy of amyotrophic lateral sclerosis;
肌萎缩侧索硬化的药物治疗进展
2.
GDNF protect the model of amyotrophic lateral sclerosis;
胶质细胞源性神经营养因子对肌萎缩侧索硬化症培养模型的保护作用
3.
Study of electromyography in patients with amyotrophic lateral sclerosis of different stages;
不同阶段肌萎缩侧索硬化患者肌电图的研究
2) amyotrophic lateral sclerosis
肌萎缩性侧索硬化症
1.
The most common motor neuron disease in human adults is amyotrophic lateral sclerosis(ALS).
肌萎缩性侧索硬化症(ALS)是运动神经元选择性死亡而导致运动功能障碍的神经性疾病,是成年人运动神经元病中最常见的疾病。
2.
Defective glutamate uptake has been suggested to be important in connection with amyotrophic lateral sclerosis, Alzheimer s disease and Parkinson s disease.
研究表明 ,谷氨酸转运体的摄取功能障碍与肌萎缩性侧索硬化症 (amyo trophiclateralsclerosis ,ALS)、阿尔茨海默病 (Alzhei mer’sdisease ,AD)、帕金森病 (Parkinson’sdisease ,PD)等许多神经退行性病变有关 ,这一发现对于神经退行性病变的病因学和治疗学研究均具有重要意
3) Amyotrophic lateral sclerosis(ALS)
肌萎缩脊髓侧索硬化症
4) Amyotrophic lateral sclerosis
肌萎缩侧索硬化症
1.
Establishment of transgenic mouse model of familial amyotrophic lateral sclerosis and identification of the filial generation;
家族性肌萎缩侧索硬化症转基因鼠的繁殖和鉴定
2.
Lesion of the peripheral nerve in amyotrophic lateral sclerosis;
肌萎缩侧索硬化症的周围神经损害
3.
Current status and trends in the therapy of amyotrophic lateral sclerosis;
肌萎缩侧索硬化症的药物治疗研究进展
5) Amyotrophic lateral sclerosis
肌萎缩性侧索硬化
1.
Deficient RNA editing of the AMPA receptor subunit GluR2 at the Q/R site is a primary cause of neuronal death and recently has been reported to be a tightly linked etiological cause of motor neuron death in sporadic amyotrophic lateral sclerosis(ALS).
AMPA受体的谷氨酸受体2(GluR2)亚基的Q/R部位编辑率低下是散发性肌萎缩性侧索硬化(ALS)运动神经元死亡的主要原因。
6) familial amyotrophic lateral sclerosis
家族性肌萎缩侧索硬化
补充资料：肌萎缩
肌萎缩
myoatrophy
肌肉体积缩小，肌纤维变细的一种表现。多由肌肉本身疾患或神经系统功能障碍所致。部分因肢体活动减少所致者称为废用性萎缩。本病常伴有肌纤维数目减少和肌张力减弱。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条